{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:20:48Z","timestamp":1793910048126,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pharmthera.2019.04.010","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T20:13:46Z","timestamp":1556568826000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve"],"prefix":"10.1016","volume":"200","author":[{"given":"Noelle","family":"Jurcak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2019.04.010_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.12463","article-title":"Perineural invasion in pancreatic cancer: Proteomic analysis and in vitromodelling","author":"Alrawashdeh","year":"2019","journal-title":"Molecular Oncology"},{"issue":"23","key":"10.1016\/j.pharmthera.2019.04.010_bb0010","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/onc.2016.483","article-title":"Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma","volume":"36","author":"Amit","year":"2017","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrc.2016.38","article-title":"Mechanisms of cancer dissemination along nerves","volume":"16","author":"Amit","year":"2016","journal-title":"Nature Reviews Cancer"},{"issue":"22","key":"10.1016\/j.pharmthera.2019.04.010_bb0020","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1158\/0008-5472.CAN-17-1612","article-title":"Inflammatory monocytes promote perineural invasion via CCL2-mediated recruitment and cathepsin B expression","volume":"77","author":"Bakst","year":"2018","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.04.010_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc3131","article-title":"Perineural invasion and associated pain in pancreatic cancer","volume":"11","author":"Bapat","year":"2011","journal-title":"Nature Reviews Cancer"},{"issue":"7424","key":"10.1016\/j.pharmthera.2019.04.010_bb0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/0008-5472.CAN-15-2790","article-title":"LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker","volume":"78","author":"Bressy","year":"2018","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jss.2004.07.013","article-title":"Macrophage inflammatory Protein-3 alpha promotes pancreatic cancer cell invasion","volume":"123","author":"Campbell","year":"2005","journal-title":"Journal of Surgical Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0045","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.celrep.2018.03.131","article-title":"CSF1R+ macrophages sustain pancreatic tumor growth through T cell suppression and maintenance of key gene programs that define the squamous subtype","volume":"23","author":"Candido","year":"2018","journal-title":"Cell Reports"},{"issue":"41","key":"10.1016\/j.pharmthera.2019.04.010_bb0050","doi-asserted-by":"crossref","first-page":"31840","DOI":"10.1074\/jbc.M110.151696","article-title":"Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype","volume":"285","author":"Cao","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","article-title":"Impeding macrophage entry into hypoxic tumor areas by Sema3A\/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity","volume":"24","author":"Casazza","year":"2013","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.pharmthera.2019.04.010_bb0060","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/0008-5472.CAN-12-0764","article-title":"Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor","volume":"72","author":"Cavel","year":"2012","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.010_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.sla.0000217642.68697.55","article-title":"The neurotrophic factor artemin promotes pancreatic cancer invasion","volume":"244","author":"Ceyhan","year":"2006","journal-title":"Annals of Surgery"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.010_bb0070","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cancers7030838","article-title":"Neural regulation of pancreatic cancer: A novel target for intervention","volume":"7","author":"Chang","year":"2015","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.010_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0b013e31824104c5","article-title":"Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"36","author":"Chatterjee","year":"2012","journal-title":"The American Journal of Surgical Pathology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0080","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jcb.21209","article-title":"Stromal biology of pancreatic cancer","volume":"101","author":"Chu","year":"2007","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.010_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1083\/jcb.126.2.539","article-title":"Cell surface Annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C","volume":"126","author":"Chung","year":"1994","journal-title":"The Journal of Cell Biology"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.04.010_bb0090","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0095","first-page":"850","article-title":"Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer","volume":"21","author":"Dang","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.010_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju184","article-title":"Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasion","volume":"106","author":"Demir","year":"2014","journal-title":"Journal of the National Cancer Institute"},{"issue":"480","key":"10.1016\/j.pharmthera.2019.04.010_bb0105","article-title":"The microenvironment in chronic pancreatitis and pancreatic cancer induces neuronal plasticity","volume":"22","author":"Demir","year":"2010","journal-title":"Neurogastroenterology and Motility"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.010_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","article-title":"Neural plasticity in pancreatitis and pancreatic cancer","volume":"12","author":"Demir","year":"2015","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060529","article-title":"Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis","volume":"8","author":"Demir","year":"2013","journal-title":"PLoS ONE"},{"issue":"16","key":"10.1016\/j.pharmthera.2019.04.010_bb0120","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"50","key":"10.1016\/j.pharmthera.2019.04.010_bb0125","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti\u2013PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"54","key":"10.1016\/j.pharmthera.2019.04.010_bb0130","first-page":"1","article-title":"Nrf2 activation drive macrophages polarization and cancer cell epithelial- mesenchymal transition during interaction","volume":"16","author":"Feng","year":"2018","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/19336918.2016.1259057","article-title":"Hedgehog signaling stimulates tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2","volume":"11","author":"Foley","year":"2017","journal-title":"Cell Adhesion & Migration"},{"issue":"388","key":"10.1016\/j.pharmthera.2019.04.010_bb0140","doi-asserted-by":"crossref","first-page":"ra77","DOI":"10.1126\/scisignal.aaa5823","article-title":"Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer","volume":"8","author":"Foley","year":"2015","journal-title":"Science Signaling"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0145","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1158\/0008-5472.CAN-13-1012","article-title":"Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer","volume":"74","author":"Gohring","year":"2014","journal-title":"Cancer Research"},{"issue":"March","key":"10.1016\/j.pharmthera.2019.04.010_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/1535-7163.MCT-12-0809","article-title":"Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling","volume":"12","author":"Guo","year":"2013","journal-title":"Molecular Cancer Therapeutics"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0155","first-page":"825","article-title":"Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol","volume":"22","author":"Guo","year":"2009","journal-title":"Oncology Reports"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.010_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/08977190903132273","article-title":"Transforming growth factor-\u03b2 induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5 pathway","volume":"27","author":"Haas","year":"2009","journal-title":"Growth Factors"},{"issue":"14","key":"10.1016\/j.pharmthera.2019.04.010_bb0165","doi-asserted-by":"crossref","first-page":"18146","DOI":"10.18632\/oncotarget.7776","article-title":"Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.010_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1172\/JCI111716","article-title":"Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas","volume":"75","author":"Hisatomi","year":"1985","journal-title":"Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.010_bb0175","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1007\/s13277-015-4741-z","article-title":"The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer","volume":"37","author":"Hu","year":"2016","journal-title":"Tumor Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.010_bb0180","first-page":"918","article-title":"Cancer-associated stromal fibroblasts promote pancreatic tumor progression","volume":"68","author":"Hwang","year":"2008","journal-title":"Clinical Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.010_bb0185","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","article-title":"Nerve-cancer cell cross-talk: A novel promoter of tumor progression","volume":"75","author":"Jobling","year":"2015","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0190","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0195","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.biocel.2004.01.020","article-title":"Myeloid cells","volume":"36","author":"Kawamoto","year":"2004","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2014.02.019","article-title":"Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment","volume":"40","author":"Kim-Fuchs","year":"2014","journal-title":"Brain, Behavior, and Immunity"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0205","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00130404-200411000-00007","article-title":"Co-localization of macrophage inflammatory protein-3 alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion","volume":"10","author":"Kimsey","year":"2004","journal-title":"The Cancer Journal"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nature Reviews. Disease Primers"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.010_bb0215","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"Journal of Surgical Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0220","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0092-8674(00)80591-7","article-title":"Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons","volume":"96","author":"Li","year":"1999","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.pharmthera.2019.04.010_bb0225","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1158\/1078-0432.CCR-13-3426","article-title":"Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer","volume":"20","author":"Li","year":"2014","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.010_bb0230","first-page":"111","article-title":"New insights into perineural invasion of pancreatic cancer: More than pain","volume":"1865","author":"Liang","year":"2016","journal-title":"BBA - Reviews on Cancer"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.04.010_bb0235","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/cncr.24396","article-title":"Perineural invasion in cancer: A review of the literature","volume":"115","author":"Liebig","year":"2009","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.010_bb0240","first-page":"1852","article-title":"Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in","volume":"23","author":"Ma","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic Cancer","volume":"3","author":"Maitra","year":"2009","journal-title":"Annual Review of Pathology"},{"issue":"21","key":"10.1016\/j.pharmthera.2019.04.010_bb0250","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1158\/0008-5472.CAN-08-1810","article-title":"The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma","volume":"68","author":"Marchesi","year":"2008","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0255","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0260","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.4049\/jimmunol.1101435","article-title":"Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages","volume":"188","author":"Meda","year":"2012","journal-title":"The Journal of Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0265","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.010_bb0270","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/ijc.22949","article-title":"Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer","volume":"121","author":"M\u00fcller","year":"2007","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0275","first-page":"596","article-title":"L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression","volume":"38","author":"Na","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00006676-199605000-00006","article-title":"Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer","volume":"12","author":"Nakao","year":"1996","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/biomedicines5040065","article-title":"Pancreatic cancer: Molecular characterization, clonal evolution and cancer stem cells","volume":"5","author":"Pelosi","year":"2017","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.010_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07497-z","article-title":"ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-\u03b2 signalling","volume":"9","author":"Pinho","year":"2018","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0295","first-page":"3015","article-title":"Norepinephrine enhances cell viability and invasion, and inhibits apoptosis of pancreatic cancer cells in a Notch-1-dependent manner","volume":"40","author":"Qian","year":"2018","journal-title":"Oncology Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.010_bb0300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","article-title":"\u03b22 adrenergic-neurotrophin feed-forward loop promotes pancreatic cancer","volume":"33","author":"Renz","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0305","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.010_bb0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/0008-5472.CAN-16-1383","article-title":"Heterogeneous stromal signaling within the tumor microenvironment controls the metastasis of pancreatic cancer","volume":"77","author":"Rucki","year":"2016","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0315","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.010_bb0320","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1073\/pnas.1512603113","article-title":"Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer","volume":"113","author":"Saloman","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.010_bb0325","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/MPA.0000000000001090","article-title":"Systemic depletion of nerve growth factor inhibits disease progression in a genetically engineered model of pancreatic ductal adenocarcinoma","volume":"47","author":"Saloman","year":"2018","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.010_bb0330","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40425-018-0435-6","article-title":"Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137 + effector T-cells in the murine model of pancreatic cancer","volume":"6","author":"Saung","year":"2018","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","article-title":"Mechanisms of hedgehog pathway activation in cancer and implications for therapy","volume":"30","author":"Scales","year":"2009","journal-title":"Trends in Pharamcological Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.010_bb0340","doi-asserted-by":"crossref","first-page":"e1511","DOI":"10.1038\/cddis.2014.557","article-title":"Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling","volume":"6","author":"Secq","year":"2015","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0345","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3892\/or.2017.5479","article-title":"Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism","volume":"37","author":"Shan","year":"2017","journal-title":"Oncology Repots"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0350","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.7314\/APJCP.2013.14.9.5403","article-title":"CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells","volume":"14","author":"Shen","year":"2013","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.04.010_bb0355","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1111\/cas.13809","article-title":"Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells","volume":"109","author":"Shi","year":"2018","journal-title":"Cancer Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.010_bb0360","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MPA.0b013e31820b5d37","article-title":"Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas","volume":"40","author":"Shimada","year":"2011","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.04.010_bb0365","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0370","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0375","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/0008-5472.CAN-13-2050","article-title":"Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma","volume":"74","author":"Stopczynski","year":"2014","journal-title":"Cancer Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.010_bb0380","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.ejca.2014.04.010","article-title":"Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas","volume":"50","author":"Sugimoto","year":"2014","journal-title":"European Journal of Cancer"},{"issue":"18","key":"10.1016\/j.pharmthera.2019.04.010_bb0385","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.7150\/thno.26546","article-title":"The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer","volume":"8","author":"Sun","year":"2018","journal-title":"Theranostics"},{"issue":"49","key":"10.1016\/j.pharmthera.2019.04.010_bb0390","doi-asserted-by":"crossref","first-page":"86488","DOI":"10.18632\/oncotarget.21212","article-title":"PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-\u03baB pathway","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"76","key":"10.1016\/j.pharmthera.2019.04.010_bb0395","first-page":"1","article-title":"The role of stromal cancer-associated fibroblasts in pancreatic cancer","volume":"10","author":"Von Ahrens","year":"2017","journal-title":"Journal of Hematology & Oncology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.04.010_bb0400","first-page":"1781","article-title":"Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer associated fibroblasts","volume":"16","author":"Walter","year":"2010","journal-title":"Clinical Research"},{"issue":"32","key":"10.1016\/j.pharmthera.2019.04.010_bb0405","doi-asserted-by":"crossref","first-page":"33805","DOI":"10.18632\/oncotarget.5668","article-title":"MUC4-promoted neural invasion is mediated by the axon guidance factor netrin-1 in PDAC","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"4.1","key":"10.1016\/j.pharmthera.2019.04.010_bb0410","first-page":"679","article-title":"Effect of sensory nerves and CGRP on the development of caerulein-induced pancreatitis and pancreatic recovery","volume":"52","author":"Warzecha","year":"2001","journal-title":"Journal of Physiology and Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.04.010_bb0415","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1096\/fj.201700834R","article-title":"GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells","volume":"32","author":"Wiley","year":"2018","journal-title":"The FASEB Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0420","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.04.010_bb0425","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbagen.2016.10.006","article-title":"Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3\/Nrf2 pathway in pancreatic cancer cells","volume":"1861","author":"Wu","year":"2017","journal-title":"Biochimica et Biophysica Acta"},{"issue":"18","key":"10.1016\/j.pharmthera.2019.04.010_bb0430","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1158\/0008-5472.CAN-15-3264","article-title":"Cancer-associated fibroblasts in pancreatic cancer are reprogrammed by tumor-induced alterations in genomic DNA methylation","volume":"76","author":"Xiao","year":"2016","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.04.010_bb0435","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.18632\/oncotarget.3069","article-title":"Stromal-derived factor-1\u03b1\/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer","volume":"6","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0440","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2017.03.014","article-title":"Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1\/2 signaling pathway","volume":"397","author":"Xu","year":"2017","journal-title":"Cancer Letters"},{"issue":"40","key":"10.1016\/j.pharmthera.2019.04.010_bb0445","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.3748\/wjg.v23.i40.7232","article-title":"Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer","volume":"23","author":"Yang","year":"2017","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.04.010_bb0450","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3748\/wjg.v20.i11.3018","article-title":"Midkine promotes perineural invasion in human pancreatic cancer","volume":"20","author":"Yao","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"52","key":"10.1016\/j.pharmthera.2019.04.010_bb0455","doi-asserted-by":"crossref","first-page":"87431","DOI":"10.18632\/oncotarget.13704","article-title":"Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival","volume":"7","author":"Yong","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.04.010_bb0460","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7150\/jca.10238","article-title":"Perineural invasion and TAMs in pancreatic ductal adenocarcinomas: Review of the original pathology reports using immunohistochemical enhancement and relationships with clinicopathological features","volume":"5","author":"Zeng","year":"2014","journal-title":"Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0465","first-page":"1","article-title":"Epithelial-stromal interactions in pancreatic cancer","author":"Zhang","year":"2018","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2019.04.010_bb0470","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/gutjnl-2016-312078","article-title":"Myeloid cells are required for PD-1\/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer","volume":"66","author":"Zhang","year":"2017","journal-title":"Gut"},{"issue":"20","key":"10.1016\/j.pharmthera.2019.04.010_bb0475","first-page":"6359","article-title":"Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance","volume":"73","author":"Zhang","year":"2013","journal-title":"Tumor and Stem Cell Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.04.010_bb0480","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1053\/j.gastro.2017.12.014","article-title":"Galectin-3 mediates tumor cell\u2013stroma interactions by activating pancreatic stellate cells to produce cytokines via integrin signaling","volume":"154","author":"Zhao","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.04.010_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019390","article-title":"Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.04.010_bb0490","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1200\/JCO.1999.17.8.2419","article-title":"Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer","volume":"17","author":"Zhu","year":"1999","journal-title":"Journal of Clinical Oncology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819300737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:59:07Z","timestamp":1759010347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819300737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":98,"alternative-id":["S0163725819300737"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.04.010","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}